MediciNova Announces that BioComo's Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology - StreetInsider.com

MediciNova Announces that BioComo's Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology  StreetInsider.com